Swahili
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Steroids in Treatment of Viral Encephalitis

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
Kiungo kimehifadhiwa kwenye clipboard
HaliBado kuajiri
Wadhamini
Assiut University

Maneno muhimu

Kikemikali

acute viral encephalitis is used to describe restricted CNS involvement (namely, involvement of the brain, sparing the meninges)

Maelezo

Viral encephalitis is a medical emergency The spectrum of brain involvement and the prognosis are dependent mainly on the specific pathogen and the immunological state of the host.

Although specific therapy is limited to only several viral agents, correct immediate diagnosis and introduction of symptomatic and specific therapy has a dramatic influence upon survival and reduces the extent of permanent brain injury in survivors Epidemiologic studies estimate the incidence of viral encephalitis at 3.5 to 7.4 per 100,000 persons per year. Overall, viruses are the most common cause of encephalitis.

The Centers for Disease Control and Prevention (CDC) estimates an annual incidence of approximately 20,000 new cases of encephalitis in the United States; most are mild in nature. The mortality depends largely on the etiologic agent of the encephalitis.

Herpes simplex virus (HSV) encephalitis (HSVE) is the most common cause of sporadic encephalitis in humans. More than 90% of HSVE cases are attributable to HSV type-1 (HSV-1). Approximately 5% of them are caused by HSV type-2 HSVE is a severe disease, often leading to high morbidity (40%) and mortality (up to 15% in treated cases and 70% in untreated cases) Patients with encephalitis have an altered mental status ranging from subtle deficits to complete unresponsiveness. The typical clinical presentation includes a rapid onset of fever and impaired consciousness, often accompanied by focal neurologic signs and seizures.

The current treatment of choice is the viral replication inhibitor acyclovir. Although highly effective in reducing mortality, it only results in complete recovery in one-half of patients . Steroid therapy as an adjunctive therapy in HSVE has good anti inflammatory effect. Steroid therapy has both anti inflammatory and immunosuppressive property.

The diagnosis of viral encephalitis is suspected in the context of a febrile disease accompanied by headache, altered level of consciousness, and symptoms and signs of cerebral dysfunction. These may consist of abnormalities that can be categorized into four: cognitive dysfunction (acute memory disturbances), behavioural changes (disorientation, hallucinations, psychosis, personality changes, agitation), focal neurological abnormalities (such as anosmia, dysphasia, hemiparesis, hemianopia etc.) and seizures. After the diagnosis is suspected, the approach should consist of obtaining a meticulous history and a careful general and neurological examination.

Tarehe

Imethibitishwa Mwisho: 12/31/2019
Iliyowasilishwa Kwanza: 09/23/2019
Uandikishaji uliokadiriwa Uliwasilishwa: 09/23/2019
Iliyotumwa Kwanza: 09/24/2019
Sasisho la Mwisho Liliwasilishwa: 01/27/2020
Sasisho la Mwisho Lilichapishwa: 01/28/2020
Tarehe halisi ya kuanza kwa masomo: 03/29/2020
Tarehe ya Kukamilisha Msingi iliyokadiriwa: 03/29/2021
Tarehe ya Kukamilisha Utafiti: 08/29/2021

Hali au ugonjwa

Encephalitis, Viral

Uingiliaji / matibabu

Drug: Patients will receive steroid pulse therapy

Drug: Patients will receive low dose steroids

Awamu

Awamu 4

Vikundi vya Arm

MkonoUingiliaji / matibabu
Experimental: Patients will receive steroid pulse therapy
Drug: Patients will receive steroid pulse therapy
30mg per kg per day for 5 days followed by course of oral prednisolone
Active Comparator: Patients will receive low dose steroids
Drug: Patients will receive low dose steroids
0.6mg per kg perday for 5 days

Vigezo vya Kustahiki

Zama zinazostahiki Kujifunza 1 Month Kwa 1 Month
Jinsia Inastahiki KujifunzaAll
Hupokea Wajitolea wa AfyaNdio
Vigezo

Inclusion Criteria:

- Pediatric patients who attending Neurology unit in Assiut University Children Hospital and diagnosed as viral encephalitis.

- Age 1month : 18 year .

- Both sexes.

- Diagnosis of viral encephalitis will be confirmed by clinical picture ,investigations and exclusion of other causes of encephalopathy

Exclusion Criteria:

- Autoimmune encephalitis

- Renal failure (any patient with abnormal renal function tests will be excluded)

- Hepatic failure ( any patient with abnormal liver function tests will be excluded)

- Metabolic disorders (any patient with abnormal level of ammonia and lactate )

Matokeo

Hatua za Matokeo ya Msingi

1. Conscious level [5 days]

Glasgow coma scale

Jiunge na ukurasa
wetu wa facebook

Hifadhidata kamili ya mimea ya dawa inayoungwa mkono na sayansi

  • Inafanya kazi katika lugha 55
  • Uponyaji wa mitishamba unaungwa mkono na sayansi
  • Kutambua mimea kwa picha
  • Ramani ya GPS inayoshirikiana
  • Soma machapisho ya kisayansi yanayohusiana na utafutaji wako
  • Tafuta mimea ya dawa na athari zao
  • Panga maslahi yako na fanya tarehe ya utafiti wa habari, majaribio ya kliniki na ruhusu

Andika dalili au ugonjwa na usome juu ya mimea ambayo inaweza kusaidia, chapa mimea na uone magonjwa na dalili ambazo hutumiwa dhidi yake.
* Habari zote zinategemea utafiti wa kisayansi uliochapishwa

Google Play badgeApp Store badge